BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25486469)

  • 1. Sirtuin deacetylases: a new target for melanoma management.
    Wilking MJ; Singh CK; Nihal M; Ndiaye MA; Ahmad N
    Cell Cycle; 2014; 13(18):2821-6. PubMed ID: 25486469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
    Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
    Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation.
    Wilking MJ; Singh C; Nihal M; Zhong W; Ahmad N
    Arch Biochem Biophys; 2014 Dec; 563():94-100. PubMed ID: 24751483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells.
    Orecchia A; Scarponi C; Di Felice F; Cesarini E; Avitabile S; Mai A; Mauro ML; Sirri V; Zambruno G; Albanesi C; Camilloni G; Failla CM
    PLoS One; 2011; 6(9):e24307. PubMed ID: 21931678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.
    Dai W; Zhou J; Jin B; Pan J
    Sci Rep; 2016 Mar; 6():22622. PubMed ID: 26940009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular molecular and proteomic profiling deciphers the SIRT1 controlled cell death pathways in esophageal adenocarcinoma cells.
    Jiang H; Patil K; Vashi A; Wang Y; Strickland E; Pai SB
    Cancer Treat Res Commun; 2021; 26():100271. PubMed ID: 33341453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiproliferative and apoptotic effects of sirtinol, a sirtuin inhibitor on human lung cancer cells by modulating Akt/β-catenin-Foxo3a axis.
    Fong Y; Lin YC; Wu CY; Wang HM; Lin LL; Chou HL; Teng YN; Yuan SS; Chiu CC
    ScientificWorldJournal; 2014; 2014():937051. PubMed ID: 25184156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.
    Jin Y; Cao Q; Chen C; Du X; Jin B; Pan J
    BMC Cancer; 2015 Apr; 15():226. PubMed ID: 25884180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.
    Pal S; Shankar BS; Sainis KB
    Cytokine; 2013 Oct; 64(1):196-207. PubMed ID: 23972545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells.
    Kalle AM; Mallika A; Badiger J; Alinakhi ; Talukdar P; Sachchidanand
    Biochem Biophys Res Commun; 2010 Oct; 401(1):13-9. PubMed ID: 20813094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
    Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
    Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP.
    Wang TT; Schoene NW; Kim EK; Kim YS
    Mol Carcinog; 2013 Sep; 52(9):676-85. PubMed ID: 22495798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach.
    Singh CK; George J; Nihal M; Sabat G; Kumar R; Ahmad N
    Oncotarget; 2014 Apr; 5(7):1987-99. PubMed ID: 24743044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair.
    Spallotta F; Cencioni C; Straino S; Nanni S; Rosati J; Artuso S; Manni I; Colussi C; Piaggio G; Martelli F; Valente S; Mai A; Capogrossi MC; Farsetti A; Gaetano C
    J Biol Chem; 2013 Apr; 288(16):11004-12. PubMed ID: 23463510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.
    George J; Nihal M; Singh CK; Ahmad N
    Mol Carcinog; 2019 Oct; 58(10):1876-1885. PubMed ID: 31292999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells.
    Kozako T; Aikawa A; Shoji T; Fujimoto T; Yoshimitsu M; Shirasawa S; Tanaka H; Honda S; Shimeno H; Arima N; Soeda S
    Int J Cancer; 2012 Nov; 131(9):2044-55. PubMed ID: 22322739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichostatin A and Sirtinol Regulate the Expression and Nucleocytoplasmic Shuttling of Histone Deacetylases in All-Trans Retinoic Acid-Induced Differentiation of Neuroblastoma Cells.
    Jang BG; Choi B; Kim S; Lee JY; Kim MJ
    J Mol Neurosci; 2018 Apr; 64(4):501-511. PubMed ID: 29516351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
    Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
    Mai A; Massa S; Lavu S; Pezzi R; Simeoni S; Ragno R; Mariotti FR; Chiani F; Camilloni G; Sinclair DA
    J Med Chem; 2005 Dec; 48(24):7789-95. PubMed ID: 16302818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current State of NAD
    Schiedel M; Robaa D; Rumpf T; Sippl W; Jung M
    Med Res Rev; 2018 Jan; 38(1):147-200. PubMed ID: 28094444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.